Skhumbuzo Ngozwana

Dr. Ngozwana is President of Serenus Biotherapeutics Limited. He is an internationally renowned African Pharma expert, who has served as a consultant to the World Health Organization (WHO), United Nations Industrial Development Organization (UNIDO), the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United States Pharmacopeial Convention (USP) among others. His last assignment was with WHO where he was involved in the development of, and co-authored the Ethiopian Pharmaceutical Sector Strategy and Action Plan. Dr. Ngozwana also worked as the lead consultant for the UNIDO, working on the African Union Commission -UNIDO partnership on the development of the Pharmaceutical Manufacturing Plan for Africa, which he co-authored. Prior to that, he served as Deputy CEO of Cipla Medpro, one of Africa’s largest pharmaceutical companies. He also served as Chairman of the National Association of Pharmaceutical Manufacturers of South Africa, the founding chairman of the Southern African Generic Medicines Association; and a founding member of the Federation of African Pharmaceutical Manufacturers Association (FAPMA); of which he is a board member. He sits on the board of the Biovac Initiative (a South African Vaccine manufacturer), and is a member of the South African Government’s Department of Science and Technology’s Health Innovation Coordinating Committee; and the Council for Scientific and Industrial Research’s Biosciences Research Advisory Panel. Dr. Ngozwana qualified as a medical doctor at the University of Cape Town before obtaining an MBA at the Gordon Institute of Business Science and a master’s degree in Clinical Pharmacology, both from the University of Pretoria.